Chimeric antigen receptor T-regulatory cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Chimeric antigen receptor T-regulatory cell therapy, covering 2026-07-02 to 2026-07-02. Get the full timeline:
Most recent: Clinical Trial Results: Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients [Phase 1, Phase 2]